Concepedia

Author

Elisabetta Todisco

Istituti di Ricovero e Cura a Carattere ScientificoORCID

Also Known As

E Todisco, E. Todisco, ELISABETTA TODISCO, Elisabetta Todisco, Todisco, Elisabetta

191

Publications

2.6K

Citations

26

H-Index

66

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere ScientificoEuropean Institute of OncologyFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoUniversity of MilanFondazione Humanitas per la Ricerca
ET

About

Elisabetta Todisco is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

20

1.4K

2

Health Sciences

6

6

135

3

Arts

1

1

14

4

Language Studies

1

1

14

5

Biostatistics

1

1

70

Elisabetta Todisco

×

44

Publications

2.3K

Citations

25

H-Index

YearCitations

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

Fabio Ciceri, Chiara Bonini, Maria Teresa Lupo Stanghellini,

The Lancet Oncology

2009

481

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study

Livio Pagano, Caterina Giovanna Valentini, Alessandro Pulsoni,

Haematologica

2012

334

Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin’s lymphoma

Anna Maria Raiola, Alida Dominietto, Riccardo Varaldo,

Bone Marrow Transplantation

2013

142

Interleukin-17–Producing T-Helper Cells as New Potential Player Mediating Graft-Versus-Host Disease in Patients Undergoing Allogeneic Stem-Cell Transplantation

Erica Dander, Adriana Balduzzi, Greta Zappa,

Transplantation

2009

127

Drug Compliance and Unreported Drugs in the Elderly

Alberto Spagnoli, G Ostino, Anna Dana Borga,

Journal of the American Geriatrics Society

1989

99

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System

Matteo Giovanni Della Porta, Christopher Jackson, Emilio Paolo Alessandrino,

Leukemia

2017

70

Factors affecting successful mobilization with plerixafor: an <scp>I</scp>talian prospective survey in 215 patients with multiple myeloma and lymphoma

Francesco Lanza, Roberto M. Lemoli, Attilio Olivieri,

Transfusion

2013

64

Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation

Martino Introna, Federico Lussana, Alessandra Algarotti,

Biology of Blood and Marrow Transplantation

2017

64

Clinical Profile of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate (ADC), in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Naval Daver, Pau Montesinos, Daniel J. DeAngelo,

Blood

2019

62

Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study

Naval Daver, Pau Montesinos, Daniel J. DeAngelo,

The Lancet Oncology

2024

54

Page 1